Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Tilray Inc buy Langfinger

Start price
€7.34
28.11.20 / 50%
Target price
-
28.11.21
Performance (%)
40.25%
End price
€10.30
19.11.21
Summary
This prediction ended on 19.11.21 with a price of €10.30. The BUY prediction by Langfinger for Tilray Inc saw massive gains of 40.25%. Langfinger has 50% into this prediction

Tilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.

Performance without dividends (%)
Name 1w 1m 1y 3y
Tilray Inc -14.105% -14.105% -78.620% -
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

According to Langfinger what are the pros and cons of Tilray Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by Langfinger for this prediction

In the thread Tilray Inc diskutieren

Buy Tilray Inc